Key Takeaways:

• Classification: 5-Amino-1MQ is a small-molecule quinolinium compound, not a peptide, despite being sold in the same research catalogs.
• Mechanism: It works by selectively inhibiting the NNMT enzyme, which preserves NAD+ precursor pools and methyl-donor supply in cell models.
• Research Application: Published studies use it primarily in adipocyte biology, rodent metabolic research, and cellular energy flux studies, all within preclinical settings.

If you have come across 5-Amino-1MQ while browsing research compounds, you may have noticed it sitting next to peptides on catalog pages despite being a different type of molecule entirely. It is a small compound, not a chain of amino acids, and it works through one specific enzyme rather than broad biological pathways. That distinction matters if you are trying to design a clean, well-controlled study.

At Molecular Solutions Peptides, every batch we release is tested in small quantities and verified through HPLC and mass spectrometry before it reaches a researcher’s bench. We hold our materials to a purity target above 99.5 percent, and we back that standard with independent lab results, not marketing claims.

In this piece, we will discuss what 5-Amino-1MQ is, the enzyme it targets, how that mechanism functions at the cellular level, and where it currently appears in published research.

The Chemistry And Classification Of 5-Amino-1MQ

When researchers first ask what 5-Amino-1MQ is, the answer starts with a correction: despite sharing shelf space with our peptide lineup, 5-Amino-1MQ is not a peptide at all. It is a synthetic small molecule built on a quinolinium scaffold, and that structural distinction shapes how it behaves in a lab setting. Before you evaluate any research application, you need a clear picture of what this compound actually is at the molecular level:

5-Amino-1MQ: What Is It, Structurally Speaking

5-Amino-1MQ’s structure sets it apart from the compounds it’s often shelved beside. The full chemical name is 5-amino-1-methylquinolinium, a synthetic compound with a molecular weight of 159.21 g/mol. Unlike a peptide, which links amino acids into a chain, this molecule is built from a single quinoline ring modified with an amino group and a methylated nitrogen. We supply it in this exact form for identification purposes.

The Quinolinium Backbone That Defines Its Behavior

The quinolinium backbone is what gives 5-Amino-1MQ its defining lab properties. This ring structure makes the molecule cell-permeable, allowing it to cross membranes and reach intracellular targets, a trait documented in peer-reviewed enzymology studies. In our own batch testing, we verify this structure using HPLC and mass spectrometry before any lot leaves our lab, confirming molecular identity.

Why It Appears Alongside Our Research Peptide Catalog

5-Amino-1MQ shows up next to peptides in research catalogs, ours included, because it targets the same metabolic pathways many researchers already study through What Are Research Peptides, even though its chemistry differs entirely. Grouping by research application, not molecular class, is standard across the field. You’ll find it filed alongside peptide-based compounds for that reason, not because of shared structure.

What Does 5-Amino-1MQ Do? The NNMT Mechanism

Once you understand what 5 amino 1mq is at the structural level, the next question researchers ask is what does 5-Amino-1MQ does inside a cell. The compound’s function centers on a single enzyme target, which is part of why it stands out among small-molecule compounds in research. Before you can evaluate any downstream research application, you need to understand the mechanism itself:

The NNMT Enzyme Target

5-Amino-1MQ was developed to selectively inhibit nicotinamide N-methyltransferase, or NNMT, a cytosolic enzyme reported in some published research to be elevated in aged adipose tissue and obese skeletal muscle. NNMT methylates nicotinamide using SAM, the cell’s primary methyl donor, converting it into an inactive metabolite. Blocking this single enzyme is the compound’s defining mechanism.

How NNMT Inhibition Affects The NAD+ Pathway

Inhibiting NNMT preserves two resources at once: the NAD+ precursor pool and the SAM methyl-donor supply. Some published cell-culture data have reported increased intracellular NAD+ levels and reduced levels of the byproduct 1-methylnicotinamide in differentiated adipocytes following treatment. We reference this mechanism because it’s the basis researchers use to design NAD+ flux and cellular bioenergetics studies with our material.

Selectivity In Cell And Rodent Models

What separates 5-Amino-1MQ from broader-acting compounds is its selectivity. Some published research has reported low micromolar IC50 values against NNMT with minimal activity against related methyltransferases in binding kinetics screening. That specificity is why you’ll see it used as a targeted chemical probe in diet-induced obesity and adipocyte research models rather than as a general metabolic agent.

What Is 5-Amino-1MQ Used For in Laboratory Research?

With the mechanism established, the natural next question is what 5-amino-1-methylquinoline is used for in an actual research setting. The compound has become a common chemical probe across several areas of preclinical metabolic research, each directly tied to its selective inhibition of NNMT. Before choosing 5-Amino-1MQ for a specific protocol, it helps to see where the published research actually concentrates:

Adipocyte And Fat-Cell Biology Studies

Much of the preclinical literature on 5-Amino-1MQ focuses on adipocyte research, in which NNMT expression is reported to increase in obese adipose tissue. Some cell-culture studies have reported reduced lipogenesis in differentiated adipocytes following treatment. We supply this compound at verified purity specifically because that consistency matters when you’re isolating a single enzymatic effect in fat-cell models.

Rodent Metabolic And Body Composition Research

Diet-induced obese mouse models have been used in published research protocols to track body composition and glucose homeostasis endpoints. This is one of the more frequently referenced rodent studies involving the compound, though the overall body of research remains limited. Our batches are tested to support that same level of experimental precision.

Cellular Energy And NAD+ Flux Research

Researchers also use 5-Amino-1MQ to study cellular bioenergetics, specifically NAD+ flux and sirtuin activity, since NNMT inhibition directly preserves the NAD+ precursor pool. This makes it a useful tool alongside the best research peptides for laboratory use when a study design calls for probing energy metabolism pathways at the cellular level rather than through broader interventions.

Final Thoughts

5-Amino-1MQ occupies an unusual spot in the research world: a small molecule sold alongside peptides, studied for a single enzyme target with outsized influence on cellular metabolism. Its value in the lab comes from that precision. NNMT sits at the intersection of NAD+ availability and methyl-donor economy, and a compound built to block it selectively gives researchers a cleaner variable to test than most broader-acting alternatives.

We supply this material because that level of specificity is worth taking seriously, and we hold every batch to the same purity and identity-verification standards we apply across our catalog. If you’ve been asking what 5-Amino-1MQ is and whether it fits your protocol, the published data is still early and largely limited to cell and animal models, which is worth keeping in mind as you read further. What matters most is that you have accurate information about what this compound is and how it behaves before you decide whether it fits your own research.

Disclaimer: All products sold by Molecular Solutions Peptides are intended strictly for laboratory research use only (RUO), not for human consumption, diagnostic use, or therapeutic use. These compounds have not been evaluated or approved by the FDA for any purpose. See our RUO Policy for full terms.